Literature DB >> 18039919

In vitro antifungal susceptibilities of five species of sporothrix.

Rita Marimon1, Carolina Serena, Josepa Gené, Josep Cano, Josep Guarro.   

Abstract

Ninety-two isolates belonging to five species of the Sporothrix schenckii complex were tested in vitro against 12 antifungal agents, using a reference microdilution method. There were significant differences among the species; Sporothrix brasiliensis was the species that showed the best response to antifungals, and S. mexicana had the worst response. In general, terbinafine was the most active drug, followed by ketoconazole and posaconazole.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039919      PMCID: PMC2224726          DOI: 10.1128/AAC.01012-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.

Authors:  R J Hay
Journal:  Br J Dermatol       Date:  1999-11       Impact factor: 9.302

Review 2.  Sporotrichosis.

Authors:  T De Araujo; A C Marques; F Kerdel
Journal:  Int J Dermatol       Date:  2001-12       Impact factor: 2.736

3.  Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.

Authors:  M R McGinnis; N Nordoff; R K Li; L Pasarell; D W Warnock
Journal:  Med Mycol       Date:  2001-08       Impact factor: 4.076

4.  Gene genealogies, cryptic species, and molecular evolution in the human pathogen Coccidioides immitis and relatives (Ascomycota, Onygenales).

Authors:  V Koufopanou; A Burt; T Szaro; J W Taylor
Journal:  Mol Biol Evol       Date:  2001-07       Impact factor: 16.240

5.  An evaluation of the in vitro activity of terbinafine.

Authors:  C J Jessup; N S Ryder; M A Ghannoum
Journal:  Med Mycol       Date:  2000-04       Impact factor: 4.076

6.  Activity of terbinafine against serious fungal pathogens.

Authors:  N S Ryder
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

Review 7.  Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.

Authors:  A Pérez
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

8.  Treatment of human cutaneous sporotrichosis with itraconazole.

Authors:  I A Conti Díaz; E Civila; E Gezuele; M Lowinger; L Calegari; D Sanabria; L Fuentes; D Da Rosa; G Alzueta
Journal:  Mycoses       Date:  1992 May-Jun       Impact factor: 4.377

9.  Efficacies of four antifungal agents in experimental murine sporotrichosis.

Authors:  V L Kan; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

10.  Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest.

Authors:  Rita Marimon; Josep Cano; Josepa Gené; Deanna A Sutton; Masako Kawasaki; Josep Guarro
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

View more
  62 in total

1.  Disseminated Sporothrix brasiliensis infection with endocardial and ocular involvement in an HIV-infected patient.

Authors:  Mario León Silva-Vergara; Zoilo Pires de Camargo; Patricia Ferreira Silva; Michel Reis Abdalla; Ricardo Nilsson Sgarbieri; Anderson Messias Rodrigues; Keila Cristina dos Santos; Cristina Hueb Barata; Kennio Ferreira-Paim
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Evaluation of the origin of a sample of Sporothrix schenckii that caused contamination of a researcher in Southern Brazil.

Authors:  Melissa Fontes Landell; Cheila Denise Ottonelli Stopiglia; Raisa G Billodre; Daiane Heidrich; Julia Medeiros Sorrentino; Marilene H Vainstein; Maria Lúcia Scroferneker; Patricia Valente
Journal:  Mycopathologia       Date:  2010-09-12       Impact factor: 2.574

3.  In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.

Authors:  Yang Song; Shanshan Li; Ying Shi; Lipei Zhao; Yu Cui; Lei Yao; Yu Zhen; Ruili Chen; Yan Cui
Journal:  Braz J Microbiol       Date:  2020-06-17       Impact factor: 2.476

4.  Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis.

Authors:  Dayvison F S Freitas; Suelen S Santos; Rodrigo Almeida-Paes; Manoel M E de Oliveira; Antonio C F do Valle; Maria Clara Gutierrez-Galhardo; Rosely M Zancopé-Oliveira; Joshua D Nosanchuk
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 5.  Pharmacokinetic/pharmacodynamic profile of posaconazole.

Authors:  Yanjun Li; Ursula Theuretzbacher; Cornelius J Clancy; M Hong Nguyen; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

6.  Case report: Sporotrichosis from the Northern Territory of Australia.

Authors:  Shradha Subedi; Sarah E Kidd; Robert W Baird; Nicholas Coatsworth; Anna P Ralph
Journal:  Am J Trop Med Hyg       Date:  2014-09-08       Impact factor: 2.345

7.  Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India.

Authors:  Shivaprakash M Rudramurthy; Shamanth A Shankarnarayan; Basavaraj M Hemashetter; Santwana Verma; Smriti Chauhan; Reema Nath; Jayanthi Savio; Malini Capoor; Harsimran Kaur; Anup K Ghosh; Arunaloke Chakrabarti
Journal:  Braz J Microbiol       Date:  2020-07-30       Impact factor: 2.476

8.  An environmental Sporothrix as a cause of corneal ulcer.

Authors:  Annie S Morrison; Shawn R Lockhart; Jennifer G Bromley; Joung Y Kim; Eileen M Burd
Journal:  Med Mycol Case Rep       Date:  2013-04-10

9.  Sporothrix schenckii sensu stricto isolated from soil in an armadillo's burrow.

Authors:  Anderson Messias Rodrigues; Eduardo Bagagli; Zoilo Pires de Camargo; Sandra de Moraes Gimenes Bosco
Journal:  Mycopathologia       Date:  2014-02-28       Impact factor: 2.574

10.  Rare arthroconidial fungi in clinical samples: Scytalidium cuboideum and Arthropsis hispanica.

Authors:  Alejandra Giraldo; Deanna A Sutton; Josepa Gené; Annette W Fothergill; Josep Cano; Josep Guarro
Journal:  Mycopathologia       Date:  2012-10-17       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.